Treatment and Follow-up of Patients with Positive 64Cu-SAR-BBN PET Findings
| Lesion location | Lesional SUVmax | TBR ratio | Treatment received | Follow-up | Imaging outcome | ||||
|---|---|---|---|---|---|---|---|---|---|
| 1 h | 3 h | 24 h | 1 h | 3 h | 24 h | ||||
| Local recurrence | 5.2 | — | 2.9 | 26 | b | 29.0 | Radiotherapy | PSA reduction | True-positive |
| Local recurrence | 3.0 | 0.9 | — | 4.0 | 2.3 | Radiotherapy | PSA reduction | True-positive | |
| Local recurrence | 4.8 | 3.9 | 0.6 | 8.0 | 9.8 | 6.0 | Biopsy planned | PSA stable | Not verified |
| Pelvic node | 4.3 | 4.7 | — | 4.8 | 9.4 | Radiotherapy | PSA reduction | True-positive | |
| Pelvic node | 4.5 | 3.2 | — | 6.1 | 8.0 | Radiotherapy | No PSA reduction | False-positive | |
| Pelvic node | 4.0 | 1.3 | 0.6 | 6.0 | 4.3 | 3.0 | None | PSA increase | Not verified |
| Pelvic node | 3.3 | 1.6 | — | 4.7 | 4.0 | ADT commenced | PSA reduction | Not verified | |
| Pelvic node | 3.0 | 3.1 | 2.0 | 5.0 | 10 | 20.0 | Radiotherapy | PSA increase | False-positive |
| Left lung | 8.9 | 8.6 | 4.2 | 12.7 | 17.2 | 42.0 | Surgical | Histologic confirmation | True-positive |
| Right lung | 3.0 | 3.1 | 3.5 | 3.1 | 6.2 | 17.5 | ADT commenced | PSA reduction | Not verified |
| L4 vertebra | 4.4 | 3.1 | 1.8 | 5.0 | 10 | 9.0 | Radiotherapy | Findings confirmed on MRI | True-positive |
TBR = tumor-to-background ratio.